These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 511736)

  • 21. Bovine anaplasmosis can be controlled.
    Schilf EA
    J Am Vet Med Assoc; 1971 Dec; 159(11):1531-3. PubMed ID: 4403558
    [No Abstract]   [Full Text] [Related]  

  • 22. A proposed method of premunizing cattle with minimum inocula of Anaplasma marginale.
    Franklin TE; Huff JW
    Res Vet Sci; 1967 Oct; 8(4):415-8. PubMed ID: 6070724
    [No Abstract]   [Full Text] [Related]  

  • 23. A nationwide survey on seroprevalence of Neospora caninum infection in beef cattle in Uruguay.
    Bañales P; Fernandez L; Repiso MV; Gil A; Dargatz DA; Osawa T
    Vet Parasitol; 2006 Jun; 139(1-3):15-20. PubMed ID: 16621288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody levels during bovine hemoparasitic diseases: trypanosomiasis, anaplasmosis, and babesiosis.
    James MA
    Acta Cient Venez; 1983; 34(3-4):185-90. PubMed ID: 6399967
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunization against anaplasmosis and babesiosis: Part I. Evaluation of immunization using minimum infective doses under laboratory conditions.
    González EF; Todorovic RA; Thompson KC
    Tropenmed Parasitol; 1976 Dec; 27(4):427-37. PubMed ID: 1006801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplasmosis.
    Henderson FE
    Proc Annu Meet U S Anim Health Assoc; 1969; 73():113-4. PubMed ID: 5278168
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic impact of an epizootic of bovine vesicular stomatitis in California.
    Goodger WJ; Thurmond M; Nehay J; Mitchell J; Smith P
    J Am Vet Med Assoc; 1985 Feb; 186(4):370-3. PubMed ID: 2982776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three methods of immunization against bovine anaplasmosis: evaluation of protection afforded against field challenge exposure.
    Vizcaino O; Corrier DE; Terry MK; Carson CA; Lee AJ; Kuttler KL; Ristic M; Treviño GS
    Am J Vet Res; 1980 Jul; 41(7):1066-8. PubMed ID: 7436100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Farm-level economic analysis of the US National Johne's Disease Demonstration Herd Project.
    Groenendaal H; Wolf CA
    J Am Vet Med Assoc; 2008 Dec; 233(12):1852-8. PubMed ID: 19072597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durably controlling bovine hypodermosis.
    Boulard C
    Vet Res; 2002; 33(5):455-64. PubMed ID: 12387483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland.
    Häsler B; Regula G; Stärk KD; Sager H; Gottstein B; Reist M
    Prev Vet Med; 2006 Dec; 77(3-4):230-53. PubMed ID: 16982104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An attenuated Anaplasma marginale vaccine.
    Ristic M; Sibinovic S; Welter CJ
    Proc Annu Meet U S Anim Health Assoc; 1968; 72():56-69. PubMed ID: 5257490
    [No Abstract]   [Full Text] [Related]  

  • 33. A new inactivated vaccine for bovine anaplasmosis.
    Wilson JS; Trace JC
    Bull Off Int Epizoot; 1966 May; 66(1):897-902. PubMed ID: 6011941
    [No Abstract]   [Full Text] [Related]  

  • 34. Iatrogenic transmission of Anaplasma marginale in beef cattle.
    Reeves JD; Swift BL
    Vet Med Small Anim Clin; 1977 May; 72(5):911-4. PubMed ID: 586056
    [No Abstract]   [Full Text] [Related]  

  • 35. Anaplasma marginale: lack of cross-protection between strains that share MSP1a variable region and MSP4.
    Ocampo Espinoza V; Vázquez JE; Aguilar MD; Ortiz MA; Alarcón GJ; Rodríguez SD
    Vet Microbiol; 2006 Apr; 114(1-2):34-40. PubMed ID: 16386388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplasma marginale field challenge: protection by an inactivated immunogen that shares partial sequence of msp1alpha variable region with the challenge strain.
    Vega LE; Rodríguez SD; Alarcón GJ; Flores RL; Ocampo RJ; Ortiz MA; de la Torre JF; Ramírez EE
    Vaccine; 2007 Jan; 25(3):519-25. PubMed ID: 17049686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An attenuated Anaplasma marginale vaccine in Peru.
    Lora CA; Koechlin A
    Am J Vet Res; 1969 Nov; 30(11):1993-8. PubMed ID: 5388317
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparisons of serotests with calf inoculations for detection of carriers in anaplasmosis- vaccinated cattle.
    Luther DG; Cox HU; Nelson WO
    Am J Vet Res; 1980 Dec; 41(12):2085-6. PubMed ID: 7225207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence and economic importance of bovine fasciolosis in Kenya--an analysis of abattoir data.
    Kithuka JM; Maingi N; Njeruh FM; Ombui JN
    Onderstepoort J Vet Res; 2002 Dec; 69(4):255-62. PubMed ID: 12625377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.